Santos Summarizes Key Updates From EMPOWER-Lung 1 and EMPOWE

Dr Santos discusses findings from the EMPOWER-Lung 3 trial of cemiplimab plus chemotherapy in patients with advanced non–small cell lung cancer, as well as data from subgroup analyses of the EMPOWER-Lung 1 trial of cemiplimab monotherapy in patients with NSCLC and a PD-L1 score over 50%.

Related Keywords

Boca Raton , Florida , United States , Edgardos Santos , Ashling Wahner , Florida Atlantic University In Boca Raton , Twitter , Florida Society Of Clinical Oncology Membership Committee , Regeneron Pharmaceuticals , Linkedin , Facebook , Live On Air , Florida Atlantic University , Florida Society , Clinical Oncology Membership , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music , D , Naacp , Ccp , Empower Lung 1 Trial , Nct03088540 , Empower Lung 3 Trial , Nct03409614 , Florida Society Of Clinical Oncology , Cemiplimab Plus Chemotherapy , Patients With Advanced Non Small Cell Lung Cancer ,